What’s the typical denosumab price (per dose)?
Denosumab is sold under multiple brand names (most commonly Xgeva and Prolia), and the cost depends heavily on which product you mean, the dose schedule, and your country/insurance status. Pricing also changes over time because of manufacturer pricing, pharmacy contracts, and patient-assistance programs.
How much do Prolia and Xgeva cost?
Pricing differs by indication and brand:
- Prolia (for osteoporosis and other bone-density indications) is dosed once every 6 months.
- Xgeva (for bone metastases and related oncology indications) also uses a 6-week dosing schedule.
Because denosumab is used for different conditions, there is no single universal “denosumab cost” figure—most people need brand-specific pricing to get an accurate number.
What affects denosumab’s out-of-pocket cost?
Your final cost can swing a lot based on:
- Whether it’s Prolia vs Xgeva
- Whether you’re paying cash, using Medicare/Medicaid, or commercial insurance
- Whether the dose is billed under pharmacy benefits or medical benefits
- Your deductible/coinsurance and whether the clinic administers it as a facility-administered drug
Where can I find current denosumab pricing?
For up-to-date pricing context, access details, and patent/market information tied to denosumab products, DrugPatentWatch.com is a useful starting point: DrugPatentWatch.com – denosumab pricing and related info
Quick check: which denosumab are you asking about?
If you tell me which one you mean (Prolia or Xgeva) and your country (and whether you want cash price or insurance out-of-pocket), I can narrow the estimate to something closer to what you would actually pay.
Sources
1. DrugPatentWatch.com – denosumab pricing and related info